The Efficacy and Safety of Yokukansankachimpihange for Treating Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: An Open-Label Pilot Study

ISSN Print: 2169-2459
ISSN Online: 2169-2467

Website: https://www.scirp.org/journal/aad
E-mail: aad@scirp.org

"The Efficacy and Safety of Yokukansankachimpihange for Treating Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: An Open-Label Pilot Study"
written by Ryutaro Arita, Tetsuhiro Yoshino, Miwako Ohgishi, Takuya Hamaguchi, Yuko Horiba, Kaori Sawai, Kei Funaki, Hajime Tabuchi, Mizuki Oka, Takahito Yoshizaki, Kenji Watanabe, Masaru Mimura,
published by Advances in Alzheimer's Disease, Vol.7 No.4, 2018

has been cited by the following article(s):

[1]	Yokukansankachimpihange improves the social isolation-induced sleep disruption and allopregnanolone reduction in mice
	2020

[2]	Yokukansankachimpihange, a traditional Japanese (Kampo) medicine, enhances the adaptation to circadian rhythm disruption by increasing endogenous …
	2020

[3]	Comparison of the Effects of Yokukansan and Yokukansankachimpihange on Glutamate Uptake by Cultured Astrocytes and Glutamate-Induced Excitotoxicity in Cultured PC12 Cells
	Evidence-Based Complementary and Alternative Medicine, 2019